Abstract
The co-chaperone p50/Cdc37 is an important partner for Hsp90, assisting in molecular chaperone activities, particularly with regard to the regulation of protein kinases. Analysis of the structure of Hsp90-Cdc37-kinase complexes demonstrates the way in which Cdc37 interacts with and controls the folding of a large proportion of intracellular protein kinases. This co-chaperone thus stands at the hub of a multitude of intracellular signaling networks. Indeed, the influence of Cdc37 reaches beyond the housekeeping pathways of protein folding into the regulation of a wide range of cellular processes. This co-chaperone has attracted attention as a potential intermediate in carcinogenesis. Cdc37 is an attractive potential target in cancer due to (1) high expression in a number of tumor types and (2) control of multiple signaling pathways. These properties indicate (3) a potential for selectivity due to its elevated expression in malignant cells and (4) robustness, as the co-chaperone may control multiple growth signaling pathways and thus be less prone to evolution of resistance than less versatile oncoproteins. Cdc37 may also be involved in other aspects of pathophysiology and has been shown to be secreted in exosomes. Protein aggregation disorders have been linked to age-related declines in molecular chaperones and co-chaperones. Cdc37 also appears to be a potential agent in longevity due to its links to protein folding and autophagy, and it will be informative to study the role of Cdc37 maintenance/decline in aging organisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Arrigo AP (2007) The cellular “networking” of mammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis. Adv Exp Med Biol 594:14–26
Ashburner M, Bonner JJ (1979) The induction of gene activity in drosophilia by heat shock. Cell 17:241–254
Baker JD, Ozsan I, Rodriguez Ospina S, Gulick D, Blair LJ (2018) Hsp90 Heterocomplexes regulate steroid hormone receptors: from stress response to psychiatric disease. Int J Mol Sci 20(1):79
Bendell JC, Jones SF, Hart L, Pant S, Moyhuddin A, Lane CM et al (2015) A phase I study of the Hsp90 inhibitor AUY922 plus Capecitabine for the treatment of patients with advanced solid tumors. Cancer Investig 33:477–482
Bitting RL, Armstrong AJ (2013) Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer. Endocr Relat Cancer 20:R83–R99
Calderwood SK (2013) Molecular cochaperones: tumor growth and cancer treatment. Scientifica (Cairo) 2013:217513
Calderwood SK (2015) Cdc37 as a co-chaperone to Hsp90. Subcell Biochem 78:103–112
Calderwood SK, Gong J (2016) Heat shock proteins promote cancer: it's a protection racket. Trends Biochem Sci 41:311–323
Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR (2006) Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31:164–172
Calderwood SK, Murshid A, Prince T (2009) The shock of aging: molecular chaperones and the heat shock response in longevity and aging--a mini-review. Gerontology 55:550–558
Caplan AJ, Ma'ayan A, Willis IM (2007) Multiple kinases and system robustness: a link between Cdc37 and genome integrity. Cell Cycle 6:3145–3147
Chang HC, Newmyer SL, Hull MJ, Ebersold M, Schmid SL, Mellman I (2002) Hsc70 is required for endocytosis and clathrin function in drosophila. J Cell Biol 159:477–487
Chen S, Sullivan WP, Toft DO, Smith DF (1998) Differential interactions of p23 and the TPR-containing proteins Hop, Cyp40, FKBP52 and FKBP51 with Hsp90 mutants. Cell Stress Chaperones 3:118–129
Ciocca DR, Arrigo AP, Calderwood SK (2013) Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update. Arch Toxicol 87:19–48
Conde R, Xavier J, McLoughlin C, Chinkers M, Ovsenek N (2005) Protein phosphatase 5 is a negative modulator of heat shock factor 1. J Biol Chem 280:28989–28996
Cox MB, Riggs DL, Hessling M, Schumacher F, Buchner J, Smith DF (2007) FK506-binding protein 52 phosphorylation: a potential mechanism for regulating steroid hormone receptor activity. Mol Endocrinol 21:2956–2967
da Rocha DS, Friedlos F, Light Y, Springer C, Workman P, Marais R (2005) Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin. Cancer Res 65:10686–10691
D'Annessa I, Hurwitz N, Pirota V, Beretta GL, Tinelli S, Woodford M et al (2020) Design of disruptors of the Hsp90-Cdc37 interface. Molecules 25(2):360
Dey B, Lightbody JJ, Boschelli F (1996) CDC37 is required for p60v-src activity in yeast. Mol Biol Cell 7:1405–1417
Eckl JM, Rutz DA, Haslbeck V, Zierer BK, Reinstein J, Richter K (2013) Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90) motility by interaction with N-terminal and middle domain binding sites. J Biol Chem 288:16032–16042
Eckl JM, Scherr MJ, Freiburger L, Daake MA, Sattler M, Richter K (2015) Hsp90.Cdc37 complexes with protein kinases form cooperatively with multiple distinct interaction sites. J Biol Chem 290:30843–30854
Eguchi T, Prince T, Wegiel B, Calderwood SK (2015) Role and regulation of myeloid zinc finger protein 1 in cancer. J Cell Biochem 116:2146–2154
Eguchi T, Prince TL, Tran MT, Sogawa C, Lang BJ, Calderwood SK (2019) MZF1 and SCAND1 reciprocally regulate CDC37 gene expression in prostate cancer. Cancers (Basel) 11(6):792
Eguchi T, Sogawa C, Ono K, Matsumoto M, Tran MT, Okusha Y et al (2020) Cell stress induced stressome release including damaged membrane vesicles and extracellular HSP90 by prostate cancer cells. Cells 9(3):755
Ellis RJ (2007) Protein misassembly: macromolecular crowding and molecular chaperones. Adv Exp Med Biol 594:1–13
Erazo T, Moreno A, Ruiz-Babot G, Rodriguez-Asiain A, Morrice NA, Espadamala J et al (2013) Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex. Mol Cell Biol 33:1671–1686
Fliss AE, Fang Y, Boschelli F, Caplan AJ (1997) Differential in vivo regulation of steroid hormone receptor activation by Cdc37p. Mol Biol Cell 8:2501–2509
Frydman J, Nimmesgern E, Erdjument-Bromage H, Wall JS, Tempst P, Hartl FU (1992) Function in protein folding of TRiC, a cytosolic ring complex containing TCP-1 and structurally related subunits. EMBO J 11:4767–4778
Gaude H, Aznar N, Delay A, Bres A, Buchet-Poyau K, Caillat C et al (2012) Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1. Oncogene 31:1582–1591
Gerber MR, Farrell A, Deshaies RJ, Herskowitz I, Morgan DO (1995) Cdc37 is required for association of the protein kinase Cdc28 with G1 and mitotic cyclins. Proc Natl Acad Sci U S A 92:4651–4655
Giannini A, Bijlmakers MJ (2004) Regulation of the Src family kinase Lck by Hsp90 and ubiquitination. Mol Cell Biol 24:5667–5676
Gracia L, Lora G, Blair LJ, Jinwal UK (2019) Therapeutic potential of the Hsp90/Cdc37 interaction in neurodegenerative diseases. Front Neurosci 13:1263
Gray PJ Jr, Stevenson MA, Calderwood SK (2007) Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells. Cancer Res 67:11942–11950
Gray PJ Jr, Prince T, Cheng J, Stevenson MA, Calderwood SK (2008) Targeting the oncogene and kinome chaperone CDC37. Nat Rev Cancer 8:491–495
Guan SP, Seet RCS, Kennedy BK (2020) Does eNOS derived nitric oxide protect the young from severe COVID-19 complications? Ageing Res Rev 64:101201
Hanks SK, Quinn AM, Hunter T (1988) The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42–52
Harris MB, Bartoli M, Sood SG, Matts RL, Venema RC (2006) Direct interaction of the cell division cycle 37 homolog inhibits endothelial nitric oxide synthase activity. Circ Res 98:335–341
Hartl FU (1996) Molecular chaperones in cellular protein folding. Nature 381:571–579
Heinlein CA, Chang C (2004) Androgen receptor in prostate cancer. Endocr Rev 25:276–308
Huang W, Ye M, Zhang LR, Wu QD, Zhang M, Xu JH et al (2014) FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation. Mol Cancer 13:150
Jinwal UK, Abisambra JF, Zhang J, Dharia S, O'Leary JC, Patel T et al (2012) Cdc37/Hsp90 protein complex disruption triggers an autophagic clearance cascade for TDP-43 protein. J Biol Chem 287:24814–24820
Johnson BD, Schumacher RJ, Ross ED, Toft DO (1998) Hop modulates Hsp70/Hsp90 interactions in protein folding. J Biol Chem 273:3679–3686
Joo JH, Dorsey FC, Joshi A, Hennessy-Walters KM, Rose KL, McCastlain K et al (2011) Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy. Mol Cell 43:572–585
Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596(7873):583–589
Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC et al (2003) A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425:407–410
Kamal A, Boehm MF, Burrows FJ (2004) Therapeutic and diagnostic implications of Hsp90 activation. Trends Mol Med 10:283–290
Karnitz LM, Felts SJ (2007) Cdc37 regulation of the kinome: when to hold 'em and when to fold 'em. Science’s STKE 2007:pe22
Keramisanou D, Aboalroub A, Zhang Z, Liu W, Marshall D, Diviney A et al (2016) Molecular mechanism of protein kinase recognition and sorting by the Hsp90 Kinome-specific cochaperone Cdc37. Mol Cell 62:260–271
Kuravi S, Parrott E, Mudduluru G, Cheng J, Ganguly S, Saunthararajah Y et al (2019) CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas. Blood Cancer J 9:14
Lackie RE, Maciejewski A, Ostapchenko VG, Marques-Lopes J, Choy WY, Duennwald ML et al (2017) The Hsp70/Hsp90 chaperone machinery in neurodegenerative diseases. Front Neurosci 11:254
Lang BJ, Guerrero ME, Prince TL, Okusha Y, Bonorino C, Calderwood SK (2021) The functions and regulation of heat shock proteins; key orchestrators of proteostasis and the heat shock response. Arch Toxicol 95(6):1943–1970
Lavictoire SJ, Parolin DA, Klimowicz AC, Kelly JF, Lorimer IA (2003) Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII. J Biol Chem 278:5292–5299
Li R, Yuan F, Fu W, Zhang L, Zhang N, Wang Y et al (2017) Serine/threonine kinase Unc-51-like Kinase-1 (Ulk1) phosphorylates the co-chaperone cell division cycle protein 37 (Cdc37) and thereby disrupts the stability of Cdc37 client proteins. J Biol Chem 292:2830–2841
Lindquist S, Craig EA (1988) The heat-shock proteins. Annu Rev Genet 22:631–677
MacLean M, Picard D (2003) Cdc37 goes beyond Hsp90 and kinases. Cell Stress Chaperones 8:114–119
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298:1912–1934
Miyajima N, Tsutsumi S, Sourbier C, Beebe K, Mollapour M, Rivas C et al (2013) The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models. Cancer Res 73:7022–7033
Murshid A, Prince TL, Lang B, Calderwood SK (2018) Role of heat shock factors in stress-induced transcription. Methods Mol Biol 1709:23–34
Neckers L, Ivy SP (2003) Heat shock protein 90. Curr Opin Oncol 15:419–424
Nony P, Gaude H, Rossel M, Fournier L, Rouault JP, Billaud M (2003) Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37. Oncogene 22:9165–9175
Ono K, Sogawa C, Kawai H, Tran MT, Taha EA, Lu Y et al (2020) Triple knockdown of CDC37, HSP90-alpha and HSP90-beta diminishes extracellular vesicles-driven malignancy events and macrophage M2 polarization in oral cancer. J Extracell Vesicles 9:1769373
Pan T, Peng Z, Tan L, Zou F, Zhou N, Liu B et al (2018) Nonsteroidal anti-inflammatory drugs potently inhibit the replication of Zika viruses by inducing the degradation of AXL. J Virol 92(20):e01018–e01018
Perdew GH, Wiegand H, Vanden Heuvel JP, Mitchell C, Singh SS (1997) A 50 kilodalton protein associated with raf and pp60(v-src) protein kinases is a mammalian homolog of the cell cycle control protein cdc37. Biochemistry 36:3600–3607
Polissi A, Goffin L, Georgopoulos C (1995) The Escherichia coli heat shock response and bacteriophage lambda development. FEMS Microbiol Rev 17:159–169
Prince T, Matts RL (2004) Definition of protein kinase sequence motifs that trigger high affinity binding of Hsp90 and Cdc37. J Biol Chem 279:39975–39981
Prince T, Matts RL (2005) Exposure of protein kinase motifs that trigger binding of Hsp90 and Cdc37. Biochem Biophys Res Commun 338:1447–1454
Prince T, Sun L, Matts RL (2005) Cdk2: a genuine protein kinase client of Hsp90 and Cdc37. Biochemistry 44:15287–15295
Rao J, Lee P, Benzeno S, Cardozo C, Albertus J, Robins DM et al (2001) Functional interaction of human Cdc37 with the androgen receptor but not with the glucocorticoid receptor. J Biol Chem 276:5814–5820
Reed SI (1980) The selection of S. cerevisiae mutants defective in the start event of cell division. Genetics 95:561–577
Riggs DL, Cox MB, Cheung-Flynn J, Prapapanich V, Carrigan PE, Smith DF (2004) Functional specificity of co-chaperone interactions with Hsp90 client proteins. Crit Rev Biochem Mol Biol 39:279–295
Rodina A, Wang T, Yan P, Gomes ED, Dunphy MP, Pillarsetty N et al (2016) The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature 538:397–401
Roe SM, Ali MM, Meyer P, Vaughan CK, Panaretou B, Piper PW et al (2004) The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37). Cell 116:87–98
Roiniotis J, Masendycz P, Ho S, Scholz GM (2005) Domain-mediated dimerization of the Hsp90 cochaperones Harc and Cdc37. Biochemistry 44:6662–6669
Rosenzweig R, Nillegoda NB, Mayer MP, Bukau B (2019) The Hsp70 chaperone network. Nat Rev Mol Cell Biol 20:665–680
Salminen A, Lehtonen M, Paimela T, Kaarniranta K (2010) Celastrol: molecular targets of thunder god vine. Biochem Biophys Res Commun 394:439–442
Scholz GM, Cartledge K, Hall NE (2001) Identification and characterization of Harc, a novel Hsp90-associating relative of Cdc37. J Biol Chem 276:30971–30979
Schwartz H, Scroggins B, Zuehlke A, Kijima T, Beebe K, Mishra A et al (2015) Combined HSP90 and kinase inhibitor therapy: insights from the cancer genome atlas. Cell Stress Chaperones 20:729–741
Shao J, Grammatikakis N, Scroggins BT, Uma S, Huang W, Chen JJ et al (2001) Hsp90 regulates p50(cdc37) function during the biogenesis of the activeconformation of the heme-regulated eIF2 alpha kinase. J Biol Chem 276:206–214
Shao J, Prince T, Hartson SD, Matts RL (2003) Phosphorylation of serine 13 is required for the proper function of the Hsp90 co-chaperone, Cdc37. J Biol Chem 278:38117–38120
Smith JR, Workman P (2009) Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning. Cell Cycle 8:362–372
Smith JR, de Billy E, Hobbs S, Powers M, Prodromou C, Pearl L et al (2015) Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins. Oncogene 34:15–26
Stepanova L, Leng X, Parker SB, Harper JW (1996) Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev 10:1491–1502
Stepanova L, Finegold M, DeMayo F, Schmidt EV, Harper JW (2000a) The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues. Mol Cell Biol 20:4462–4473
Stepanova L, Yang G, DeMayo F, Wheeler TM, Finegold M, Thompson TC et al (2000b) Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia. Oncogene 19:2186–2193
Taipale M, Krykbaeva I, Koeva M, Kayatekin C, Westover KD, Karras GI et al (2012) Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell 150:987–1001
Vaughan CK, Mollapour M, Smith JR, Truman A, Hu B, Good VM et al (2008) Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37. Mol Cell 31:886–895
Verba KA, Wang RY, Arakawa A, Liu Y, Shirouzu M, Yokoyama S et al (2016) Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase. Science 352:1542–1547
Wang L, Zhang L, Li L, Jiang J, Zheng Z, Shang J et al (2019) Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer. Sci Adv 5:eaax2277
Wu F, Peacock SO, Rao S, Lemmon SK, Burnstein KL (2013) Novel interaction between the co-chaperone Cdc37 and rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth. J Biol Chem 288:5463–5474
Xu W, Yuan X, Xiang Z, Mimnaugh E, Marcu M, Neckers L (2005) Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex. Nat Struct Mol Biol 12:120–126
Xu W, Mollapour M, Prodromou C, Wang S, Scroggins BT, Palchick Z et al (2012) Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine. Mol Cell 47:434–443
Acknowledgments
#This work was supported by NIH research grants RO-1CA047407, R01CA119045, and RO-1CA094397.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Prince, T.L., Lang, B.J., Okusha, Y., Eguchi, T., Calderwood, S.K. (2023). Cdc37 as a Co-chaperone to Hsp90. In: Edkins, A.L., Blatch, G.L. (eds) The Networking of Chaperones by Co-Chaperones. Subcellular Biochemistry, vol 101. Springer, Cham. https://doi.org/10.1007/978-3-031-14740-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-031-14740-1_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14739-5
Online ISBN: 978-3-031-14740-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)